The SSI Mantra 3 has been installed in 75 healthcare facilities all over the world so far.|Source: SS Innovations InternationalSS Innovations International Inc.
today revealed that it has actually completed its very first robotic heart surgery in the Americas with its SSi Mantra 3 surgical robotic system.On June 8, Dr.
Juan Zuniga, a cardiothoracic surgeon at Interhospital in Guayaquil, Ecuador, ended up being the first cosmetic surgeon to carry out a robotic heart surgical treatment in the Americas and Western Hemisphere utilizing the SSi Mantra 3.
The surgical treatment included a robotic Atrial Septal Defect closure.
This procedure repair work a hole in between the upper two chambers of the heart.“& ldquo; On the heels of SSi Mantra’& rsquo; s debut in Latin American robotic surgical treatments, we decided to leverage this innovative system in complex specialties, particularly in cardiovascular surgical treatments,” & rdquo; Dr.
Zuniga stated.
& ldquo; The experience was great, this devices was very simple to deal with and manipulate, and the outcomes were effective as we did a transesophageal echocardiogram to validate the complete closure of the interaction in between the two upper chambers of the heart,” & rdquo; he said.
& ldquo; We were really delighted with the results in accomplishing a successful closure, and the patient is recuperating very well.”& rdquo; SSi Mantra aids minimally invasive proceduresInterhospital is the very first hospital in South America to set up the SSi Mantra.
It has actually carried out a variety of intricate surgeries with the surgical robotic system since its setup.“& ldquo; Because it is a minimally invasive treatment, the recovery is much quicker, bleeding much less, and given that it is done robotically, the control of the tissues is a lot more precise, therefore is the suturing,” & rdquo; added Dr.
Zuniga.
“& ldquo; It gives the surgeon the confidence that every stitch that is made with the platform is placed exactly and without complication.”& rdquo; SS Innovations described the SSi Mantra as “& ldquo; an easy to use, modular, multi-arm system.” & rdquo; Its technology features include: Three to five modular robotic armsAn open-faced ergonomic surgeon command centerA large 3D 4K monitorA touch panel display for all patient-related information displaysA virtual real-time picture of the robotic patient-side arm cartsThe capability to superimpose 3D models for diagnostic imagingA vision cart provides the table-side team with the very same magnified 3D 4K view as the surgeon to provide much better security and performance.
The SSi Mantra utilizes more than 40 types of robotic endo-surgical instruments to support different specialties, including cardiac surgery.
The system has also been medically validated in India, said SS Innovations.Now accepting session submissions!SS Innovations surpasses 4,000 robotic surgeriesLast month, SS Innovations announced that SSi Mantra has actually been utilized in 4,000 surgeries.
These operations covered more than 100 various types of surgeries without any issues, injuries, or mortalities.The Fort Lauderdale, Fla.-based business noted this included roughly 215 heart surgeries.
6 of these were successfully performed via telesurgery throughout India with the SSi Mantra 3 surgical robotic system.The Robot Report formerly talked about SS Innovations’ & rsquo; telesurgery technique with Dr.
Vishwa Srivastava, chief running officer and chairman of the board.SS Innovations said it has actually developed systems to make robotic surgery cost effective and accessible to a larger segment of the international population.
The business’& rsquo; s product range includes its proprietary SSi Mantra and its detailed suite of SSi Mudra instruments, which support a variety of surgical procedures.The company launched its latest system, the SSi Mantra 3, in July 2024.
The system received regulatory approval for remote surgical treatment and teleproctoring from the Central Drugs Standard Control Organization (CDSCO).
This opens the door for remote surgical treatments and medical education.In May 2025, SS Innovations revealed plans to submit a de novo category request to the U.S.
Food and Drug Administration for the system.The post SS Innovations finishes its very first cardiac surgical treatment in the Americas with SSi Mantra appeared first on The Robot Report.